Trump Mobilizes Military To Deliver COVID Vaccine As HHS/DoD Unveil Massive Contract For “Injection Devices” | Zero Hedge
President Trump is reportedly mobilizing the U.S. military to distribute a novel coronavirus vaccine when one becomes available and will focus first on older Americans.
“You know it’s a massive job to give this vaccine,” Trump said in an interview broadcast Thursday on Fox Business Network.
“Our military is now being mobilized so at the end of the year, we’re going to be able to give it to a lot of people very, very rapidly.”
Trump said he believes there will be a vaccine by the end of the year and the United States is mobilizing “our military and other forces” on that assumption.
And, just when you thought that things couldn’t get any stranger, TheEndOfTheAmericanDream.com’s Michael Snyder reports that two U.S. government agencies have taken things to an entirely new level.
The U.S. Department of Defense and the U.S. Department of Health and Human Services have just put out a press release that is absolutely jaw dropping, but so far hardly anyone is talking about it.
According to the press release, a 138 million dollar contract has been awarded to ApiJect Systems America for two projects known as “Project Jumpstart” and “RAPID USA”. Apparently the goal of these projects is to have vast numbers of “injection devices” ready to go once a COVID-19 vaccine becomes available. The following comes directly from the official website of the Department of Defense…
“Today the Department of Defense and the U.S. Department of Health and Human Services, announce a $138 million contract with ApiJect Systems America for “Project Jumpstart” and “RAPID USA,” which together will dramatically expand U.S. production capability for domestically manufactured, medical-grade injection devices starting by October 2020.
Spearheaded by the DOD’s Joint Acquisition Task Force (JATF), in coordination with the HHS Office of the Assistant Secretary for Preparedness and Response, the contract will support “Jumpstart” to create a U.S.-based, high-speed supply chain for prefilled syringes beginning later this year by using well-established Blow-Fill-Seal (BFS) aseptic plastics manufacturing technology, suitable for combatting COVID-19 when a safe and proven vaccine becomes available.
